Form4insider filings, from the source

SEC Form 4 · accession 0001645627-18-000008

ENDONOVO THERAPEUTICS, INC. · ENDV

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Michael Scott Mann
Officer — President
Period of report
Jan 31, 2018
Accepted (ET)
Feb 12, 2018 · 1:07 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockJan 31, 2018P1,000$0.05A24,780,189D
Common StockFeb 1, 2018P2,000$0.0564A24,782,189D
Common StockFeb 1, 2018P2,000$0.05A24,784,189D
Common StockFeb 1, 2018P2,000$0.0519A24,786,189D
Common StockFeb 1, 2018P2,000$0.0519A24,788,189D
Common StockFeb 2, 2018P2,000$0.0535A24,790,189D
Common StockFeb 2, 2018P1,000$0.052A24,791,189D
Common StockFeb 2, 2018P1,000$0.0527A24,792,189D
Common StockFeb 5, 2018P1,000$0.0507A24,793,189D
Common StockFeb 5, 2018P1,000$0.049A24,794,189D
Common StockFeb 5, 2018P1,000$0.049A24,795,189D
Common StockFeb 6, 2018P1,000$0.0475A24,796,189D
Common StockFeb 7, 2018P1,000$0.0477A24,797,189D
Common StockFeb 7, 2018P1,000$0.05A24,798,189D
Common StockFeb 7, 2018P1,000$0.05A24,799,189D
Common StockFeb 7, 2018P1,000$0.048A24,800,189D
Common StockFeb 7, 2018P1,000$0.05A24,801,189D
Common StockFeb 7, 2018P1,000$0.0507A24,802,189D
Common StockFeb 7, 2018P1,000$0.052A24,803,189D
Common StockFeb 8, 2018P1,000$0.0484A24,804,189D
Common StockFeb 8, 2018P1,000$0.0489A24,805,189D
Common StockFeb 9, 2018P1,000$0.0468A24,806,189D
Common StockFeb 9, 2018P2,000$0.0465A24,808,189D

Table II — derivative securities

No Table II lines on this filing.